Phase II Randomized Study of Short Course Radiotherapy Total Neo-adjuvant Therapy with or without Chlorophyllin in Reducing the Incidence of >/=Grade 2 Acute Toxicity in Advanced Rectal Cancer patients Suitable for Wait and Watch
View ORCID ProfileRahul Krishnatry, Vikram Gota, Debanjan Chakraborty, View ORCID ProfileVikas Ostwal, Mrs. Sadhana Kannan, Ms Pallavi Rane, Shivakumar Gudi, Mufaddal Kazi, Anant Ramaswamy, View ORCID ProfilePrabhat Bhargava, Purvi Haria, Suman K Ankathi, Munita Bal, Mukta Ramadwar, Ashwin DeSouza, Avnish Saklani, Reena Engineer
doi: https://doi.org/10.1101/2024.01.26.24301857
Rahul Krishnatry
1Department of Radiation Oncology, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, India
Roles: Principal Investigator
Vikram Gota
2Department of Clinical Pharmacology, ACTREC, Tata Memorial Centre, Homi Bhabha National Institute, Navi Mumbai, India
Roles: Co-Principal Investigator
Debanjan Chakraborty
1Department of Radiation Oncology, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, India
Roles: Co-investigator
Vikas Ostwal
4Department of Medical Oncology, Tata Memorial Hospital, Homi Bhabha National Institute, Mumbai, India
Roles: Co-investigator
Mrs. Sadhana Kannan
3Department of Epidemiology and Clinical Trials Unit, ACTREC, Tata Memorial Centre, Homi Bhabha National Institute, Navi Mumbai, India
Roles: Co-investigator
Ms Pallavi Rane
3Department of Epidemiology and Clinical Trials Unit, ACTREC, Tata Memorial Centre, Homi Bhabha National Institute, Navi Mumbai, India
Roles: Co-investigator
Shivakumar Gudi
1Department of Radiation Oncology, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, India
Roles: Co-investigator
Mufaddal Kazi
5Department of Surgical Oncology, Tata Memorial Hospital, Homi Bhabha National Institute, Mumbai, India
Roles: Co-investigator
Anant Ramaswamy
4Department of Medical Oncology, Tata Memorial Hospital, Homi Bhabha National Institute, Mumbai, India
Roles: Co-investigator
Prabhat Bhargava
4Department of Medical Oncology, Tata Memorial Hospital, Homi Bhabha National Institute, Mumbai, India
Roles: Co-investigator
Purvi Haria
6Department of Radiology, Tata Memorial Hospital, Homi Bhabha National Institute, Mumbai, India
Roles: Co-investigator
Suman K Ankathi
6Department of Radiology, Tata Memorial Hospital, Homi Bhabha National Institute, Mumbai, India
Roles: Co-investigator
Munita Bal
7Department of Pathology, Tata Memorial Hospital, Homi Bhabha National Institute, Mumbai, India
Roles: Co-investigator
Mukta Ramadwar
7Department of Pathology, Tata Memorial Hospital, Homi Bhabha National Institute, Mumbai, India
Roles: Co-investigator
Ashwin DeSouza
5Department of Surgical Oncology, Tata Memorial Hospital, Homi Bhabha National Institute, Mumbai, India
Roles: Co-investigator
Avnish Saklani
5Department of Surgical Oncology, Tata Memorial Hospital, Homi Bhabha National Institute, Mumbai, India
Roles: Co-investigator
Reena Engineer
1Department of Radiation Oncology, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, India
Roles: Co-investigator

Data Availability
The study is ongoing and data-sharing requests can be entertained based on the guidance of approved protocol limits and Ethics committee approval, as applicable.
N.A.
Posted January 28, 2024.
Phase II Randomized Study of Short Course Radiotherapy Total Neo-adjuvant Therapy with or without Chlorophyllin in Reducing the Incidence of >/=Grade 2 Acute Toxicity in Advanced Rectal Cancer patients Suitable for Wait and Watch
Rahul Krishnatry, Vikram Gota, Debanjan Chakraborty, Vikas Ostwal, Mrs. Sadhana Kannan, Ms Pallavi Rane, Shivakumar Gudi, Mufaddal Kazi, Anant Ramaswamy, Prabhat Bhargava, Purvi Haria, Suman K Ankathi, Munita Bal, Mukta Ramadwar, Ashwin DeSouza, Avnish Saklani, Reena Engineer
medRxiv 2024.01.26.24301857; doi: https://doi.org/10.1101/2024.01.26.24301857
Phase II Randomized Study of Short Course Radiotherapy Total Neo-adjuvant Therapy with or without Chlorophyllin in Reducing the Incidence of >/=Grade 2 Acute Toxicity in Advanced Rectal Cancer patients Suitable for Wait and Watch
Rahul Krishnatry, Vikram Gota, Debanjan Chakraborty, Vikas Ostwal, Mrs. Sadhana Kannan, Ms Pallavi Rane, Shivakumar Gudi, Mufaddal Kazi, Anant Ramaswamy, Prabhat Bhargava, Purvi Haria, Suman K Ankathi, Munita Bal, Mukta Ramadwar, Ashwin DeSouza, Avnish Saklani, Reena Engineer
medRxiv 2024.01.26.24301857; doi: https://doi.org/10.1101/2024.01.26.24301857
Subject Area
Subject Areas
- Addiction Medicine (349)
- Allergy and Immunology (668)
- Allergy and Immunology (668)
- Anesthesia (181)
- Cardiovascular Medicine (2648)
- Dermatology (223)
- Emergency Medicine (399)
- Epidemiology (12228)
- Forensic Medicine (10)
- Gastroenterology (759)
- Genetic and Genomic Medicine (4103)
- Geriatric Medicine (387)
- Health Economics (680)
- Health Informatics (2657)
- Health Policy (1005)
- Hematology (363)
- HIV/AIDS (851)
- Medical Education (399)
- Medical Ethics (109)
- Nephrology (436)
- Neurology (3882)
- Nursing (209)
- Nutrition (577)
- Oncology (2030)
- Ophthalmology (585)
- Orthopedics (240)
- Otolaryngology (306)
- Pain Medicine (250)
- Palliative Medicine (75)
- Pathology (473)
- Pediatrics (1115)
- Primary Care Research (452)
- Public and Global Health (6527)
- Radiology and Imaging (1403)
- Respiratory Medicine (871)
- Rheumatology (409)
- Sports Medicine (342)
- Surgery (448)
- Toxicology (53)
- Transplantation (185)
- Urology (165)